Biologics Market: By Source, By Product, By Disease, By Drug Classification, By Distribution Channel and Region Forecast 2021-2032.

download arrow download arrow Download Sample
settings arrow settings arrow email us

Biologics Market Size, Share, Growth, Trends, and Global Industry Analysis: By Source (Microbial, Mammalia Others), By Product (MABs, Vaccine, Hormones, Therapeutic Enzymes, Recombinant Proteins, Antisense, RNAi & Molecular Therapy, Blood Factors and Anticoagulants, Allergenic extracts, Human Cells and Tissues, Proteins, Gene Therapies, Cellular Therapies Others), By Disease (Oncology, Immunological Disorders, Cardiovascular Disorders, Hematological Disorders Others), By Drug Classification (Branded Drugs, Generic Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Region Forecast 2021-2032.

Report ID:61404

Published Date:Nov 2025

No of Pages:210

Format:

checked icon checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

1. Executive Summary
2. Global Biologics Market Introduction
2.1. Global Biologics Market – Taxonomy
2.2. Global Biologics Market –Definitions
2.2.1. By Source
2.2.2. By Product
2.2.3. By Disease
2.2.4. By Drug Classification
2.2.5. By Distribution Channel
2.2.6. By Region
3. Global Biologics Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Biologics Market Dynamic Factors - Impact Analysis
3.6. Global Biologics Market – Competition Landscape
4. Global Biologics Market Analysis, 2021 - 2025 and Forecast 2026 - 2032
4.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032 (Revenue, US$ Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Biologics Market, By Source, 2021 - 2025 and Forecast 2026 - 2032 (Revenue, US$ Mn)
5.1. Microbial
5.1.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032 (Revenue, US$ Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Mammalian
5.2.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032 (Revenue, US$ Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Others
5.3.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032 (Revenue, US$ Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
6. Global Biologics Market, By Product, 2021 - 2025 and Forecast 2026 - 2032 (Revenue, US$ Mn)
6.1. MABs
6.1.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032 (Revenue, US$ Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Vaccines
6.2.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032 (Revenue, US$ Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Hormones
6.3.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032 (Revenue, US$ Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Therapeutic Enzymes
6.4.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032 (Revenue, US$ Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Recombinant Proteins
6.5.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032 (Revenue, US$ Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
6.6. Antisense, RNAi & Molecular Therapy
6.6.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032 (Revenue, US$ Mn)
6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.6.3. Market Opportunity Analysis
6.7. Blood Factors and Anticoagulants
6.7.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032 (Revenue, US$ Mn)
6.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.7.3. Market Opportunity Analysis
6.8. Allergenic extracts
6.8.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032 (Revenue, US$ Mn)
6.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.8.3. Market Opportunity Analysis
6.9. Human Cells and Tissues
6.9.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032 (Revenue, US$ Mn)
6.9.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.9.3. Market Opportunity Analysis
6.10. Proteins
6.10.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032 (Revenue, US$ Mn)
6.10.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.10.3. Market Opportunity Analysis
6.11. Gene Therapies
6.11.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032 (Revenue, US$ Mn)
6.11.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.11.3. Market Opportunity Analysis
6.12. Cellular Therapies
6.12.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032 (Revenue, US$ Mn)
6.12.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.12.3. Market Opportunity Analysis
6.13. Others
6.13.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032 (Revenue, US$ Mn)
6.13.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.13.3. Market Opportunity Analysis
7. Global Biologics Market, By Disease, 2021 - 2025 and Forecast 2026 - 2032 (Revenue, US$ Mn)
7.1. Oncology
7.1.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032 (Revenue, US$ Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Immunological Disorders
7.2.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032 (Revenue, US$ Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Cardiovascular Disorders
7.3.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032 (Revenue, US$ Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Hematological Disorders
7.4.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032 (Revenue, US$ Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Others
7.5.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032 (Revenue, US$ Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
8. Global Biologics Market Forecast, By Drug Classification, 2021 - 2025 and Forecast 2026 - 2032 (Revenue, US$ Mn)
8.1. Branded Drugs
8.1.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032 (Revenue, US$ Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Generic Drugs
8.2.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032 (Revenue, US$ Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
9.  Global Biologics Market Forecast, By Distribution Channel, 2021 - 2025 and Forecast 2026 - 2032 (Revenue, US$ Mn)
9.1. Hospital Pharmacies
9.1.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032 (Revenue, US$ Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Retail Pharmacies
9.2.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032 (Revenue, US$ Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Online Pharmacies
9.3.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032 (Revenue, US$ Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
10.  Global Biologics Market Forecast, By Region, 2021 - 2025 and Forecast 2026 - 2032 (Revenue, US$ Mn)
10.1. North America
10.1.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032 (Revenue, US$ Mn)
10.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.1.3. Market Opportunity Analysis
10.2. Europe
10.2.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032 (Revenue, US$ Mn)
10.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.2.3. Market Opportunity Analysis
10.3. Asia-Pacific
10.3.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032 (Revenue, US$ Mn)
10.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.3.3. Market Opportunity Analysis
10.4. Latin America
10.4.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032 (Revenue, US$ Mn)
10.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.4.3. Market Opportunity Analysis
10.5. Middle East and Africa
10.5.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032 (Revenue, US$ Mn)
10.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.5.3. Market Opportunity Analysis
10.6. Global Biologics Market - Opportunity Analysis Index, By Source, By Product, By Disease, By Drug Classification, By Distribution Channel, and Region, 2023-2029
11. North America Biologics Market Analysis, 2021 - 2025 and Forecast 2026 - 2032 (Revenue, US$ Mn)
11.1. Source Analysis 2021 - 2025 and Forecast 2026 - 2032 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Microbial
11.1.2. Mammalian
11.1.3. Others
11.2. Product Analysis 2021 - 2025 and Forecast 2026 - 2032 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. MABs
11.2.2. Vaccines
11.2.3. Hormones
11.2.4. Therapeutic Enzymes
11.2.5. Recombinant Proteins
11.2.6. Antisense, RNAi & Molecular Therapy
11.2.7. Blood Factors and Anticoagulants
11.2.8. Allergenic extracts
11.2.9. Human Cells and Tissues
11.2.10. Proteins
11.2.11. Gene Therapies
11.2.12. Cellular Therapies
11.2.13. Others
11.3. Disease Analysis 2021 - 2025 and Forecast 2026 - 2032 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Oncology
11.3.2. Immunological Disorders
11.3.3. Cardiovascular Disorders
11.3.4. Hematological Disorders
11.3.5. Others
11.4. Drug Classification Analysis 2021 - 2025 and Forecast 2026 - 2032 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Branded Drugs
11.4.2. Generic Drugs
11.5. Distribution Channel Analysis 2021 - 2025 and Forecast 2026 - 2032 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%)
11.5.1. Hospital Pharmacies
11.5.2. Retail Pharmacies
11.5.3. Online Pharmacies
11.6. Country Analysis 2021 - 2025 and Forecast 2026 - 2032 by Revenue (US$ Mn) Y-o-Y Growth (%) and Market Share (%)
11.6.1. USA
11.6.2. Canada
11.7. North America Biologics Market - Opportunity Analysis Index, By Source, By Product, By Disease, By Drug Classification, By Distribution Channel, and Country, 2023-2029
11.8. North America Biologics Market Dynamics – Trends
12. Europe Biologics Market Analysis, 2021 - 2025 and Forecast 2026 - 2032 (Revenue, US$ Mn)
12.1. Source Analysis 2021 - 2025 and Forecast 2026 - 2032 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Microbial
12.1.2. Mammalian
12.1.3. Others
12.2. Product Analysis 2021 - 2025 and Forecast 2026 - 2032 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. MABs
12.2.2. Vaccines
12.2.3. Hormones
12.2.4. Therapeutic Enzymes
12.2.5. Recombinant Proteins
12.2.6. Antisense, RNAi & Molecular Therapy
12.2.7. Blood Factors and Anticoagulants
12.2.8. Allergenic extracts
12.2.9. Human Cells and Tissues
12.2.10. Proteins
12.2.11. Gene Therapies
12.2.12. Cellular Therapies
12.2.13. Others
12.3. Disease Analysis 2021 - 2025 and Forecast 2026 - 2032 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Oncology
12.3.2. Immunological Disorders
12.3.3. Cardiovascular Disorders
12.3.4. Hematological Disorders
12.3.5. Others
12.4. Drug Classification Analysis 2021 - 2025 and Forecast 2026 - 2032 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Branded Drugs
12.4.2. Generic Drugs
12.5. Distribution Channel Analysis 2021 - 2025 and Forecast 2026 - 2032 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%)
12.5.1. Hospital Pharmacies
12.5.2. Retail Pharmacies
12.5.3. Online Pharmacies
12.6. Country Analysis 2021 - 2025 and Forecast 2026 - 2032 by Revenue (US$ Mn) Y-o-Y Growth (%) and Market Share (%)
12.6.1. Germany
12.6.2. UK
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Russia
12.6.7. Rest of Europe
12.7. Europe Biologics Market - Opportunity Analysis Index, By Source, By Product, By Disease, By Drug Classification, By Distribution Channel, and Country, 2023-2029
12.8. Europe Biologics Market Dynamics – Trends
13. Asia-Pacific Biologics Market Analysis, 2021 - 2025 and Forecast 2026 - 2032 (Revenue, US$ Mn)
13.1. Source Analysis 2021 - 2025 and Forecast 2026 - 2032 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Microbial
13.1.2. Mammalian
13.1.3. Others
13.2. Product Analysis 2021 - 2025 and Forecast 2026 - 2032 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. MABs
13.2.2. Vaccines
13.2.3. Hormones
13.2.4. Therapeutic Enzymes
13.2.5. Recombinant Proteins
13.2.6. Antisense, RNAi & Molecular Therapy
13.2.7. Blood Factors and Anticoagulants
13.2.8. Allergenic extracts
13.2.9. Human Cells and Tissues
13.2.10. Proteins
13.2.11. Gene Therapies
13.2.12. Cellular Therapies
13.2.13. Others
13.3. Disease Analysis 2021 - 2025 and Forecast 2026 - 2032 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Oncology
13.3.2. Immunological Disorders
13.3.3. Cardiovascular Disorders
13.3.4. Hematological Disorders
13.3.5. Others
13.4. Drug Classification Analysis 2021 - 2025 and Forecast 2026 - 2032 by

Key Features of the Report

  • The market report provides granular level information about the market size, regional market share, historic market (2020-2024), and forecast (2025-2031)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The biologics market key players are: AbbVie Inc., Amgen Inc., AstraZeneca plc, GlaxoSmithKline plc, Johnson & Johnson, Merck KGaA, Novartis AG, Pfizer Inc., Sanofi, Hoffmann-La Roche Ltd

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

Content Updated Date: Feb 2026

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

Key Market Players

  • AbbVie Inc.
  • Amgen Inc.
  • AstraZeneca plc
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Merck KGaA
  • Novartis AG
  • Pfizer Inc.
  • Sanofi
  • Hoffmann-La Roche Ltd

Related Industry Reports

Lateral Flow Assays Market

Cell Biology Market

Molecular Farming Market

Near-infrared Imaging Market